Aclaris Therapeutics Inc (ACRS) is expecting 14.75% growth in the next quarter: What can investors do to maximize their returns?
On Tuesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) opened higher 5.26% from the last session, before settling in for the closing price of $1.33. Price fluctuations